Development and Initial Validation of a Frailty Score for Pediatric Patients with Congenital and Acquired Heart Disease.
Development and Initial Validation of a Frailty Score for Pediatric Patients with Congenital and Acquired Heart Disease.
复制标题
先天性和后天性心脏病儿科患者衰弱评分的制定和初步验证。
DOI:
10.1007/s00246-022-03045-1
复制
发表时间:
2024
影响因子:
1.6
通讯作者:
White,DavidA
中科院分区:
文献类型:
--
作者:
Studyvin,Sarah;Birnbaum,BrianF;Staggs,VincentS;Gross-Toalson,Jami;Shirali,Girish;Panchangam,Chaitanya;White,DavidA
Frailty is a multi-dimensional clinical syndrome that is associated with increased morbidity and mortality and decreased quality of life. Children/adolescents with heart disease (HD) perform significantly worse for each frailty domain compared to non-HD peers. Our study aimed to create a composite frailty score (CFS) that can be applied to children/adolescents with HD and evaluate associations between the CFS and outcomes. Children and adolescents (n= 30) with HD (73% single ventricle, 20% heart failure, 7% pulmonary hypertension) were recruited from 2016 to 2017 (baseline). Five frailty domains were assessed at baseline using measures validated for pediatrics: (1) Slowness: 6-min walk test; (2) Weakness: handgrip strength; (3) Fatigue: PedsQL Multi-dimensional Fatigue Scale; (4) Body composition: triceps skinfold thickness; and (5) Physical activity questionnaire. Frailty points per domain (range = 0–5) were assigned based onz-scores or raw questionnaire scores and summed to produce a CFS (0 = least frail; 25 = most frail). Nonparametric bootstrapping was used to identify correlations between CFS and cross-sectional change in outcomes over 2.2 ± 0.2 years. The mean CFS was 12.5 ± 3.5. In cross-sectional analyses of baseline data, correlations (|r|≥ 0.30) were observed between CFS and NYHA class, the number of ancillary specialists, total prescribed medications, heart failure medications/day, exercise test derived chronotropic index and percent predicted VO2peak, and between child and parent proxy PEDsQL. At follow-up, CFS was correlated with an increase in the number of heart failure medications (r= 0.31). CFS was associated with cross-sectional outcomes in youth with heart disease. Longitudinal analyses were limited by small sample sizes due to loss to follow-up.
登录
查看更多内容
影响因子:
--
作者:
Doron Portal;R. Hirsch;M. Benderly
通讯作者:
M. Benderly
DOI:
10.1186/2049-3258-72-47
发表时间:
2014
期刊:
Archives of public health = Archives belges de sante publique
影响因子:
--
作者:
Bervoets L;Van Noten C;Van Roosbroeck S;Hansen D;Van Hoorenbeeck K;Verheyen E;Van Hal G;Vankerckhoven V
通讯作者:
Vankerckhoven V
影响因子:
3.7
作者:
Voss C;Dean PH;Gardner RF;Duncombe SL;Harris KC
通讯作者:
Harris KC
影响因子:
13.1
作者:
Buta BJ;Walston JD;Godino JG;Park M;Kalyani RR;Xue QL;Bandeen-Roche K;Varadhan R
通讯作者:
Varadhan R
影响因子:
24
作者:
Atz AM;Zak V;Mahony L;Uzark K;D'agincourt N;Goldberg DJ;Williams RV;Breitbart RE;Colan SD;Burns KM;Margossian R;Henderson HT;Korsin R;Marino BS;Daniels K;McCrindle BW;Pediatric Heart Network Investigators
通讯作者:
Pediatric Heart Network Investigators